Search

Filters

Clear All
  • 14
  • 49
  • 621

Phase

  • 10
  • 16
  • 56
  • 9
  • 74
  • 3
  • 502
  • 598
  • 281
  • 670
  • 14
  • 1
  • 683

Found 684 results for in-health

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Immune Cell Differentiation and Function

M
Mark Kaplan
3 years - 100 years
Accepts healthy volunteer
All genders
The purpose of this study is to examine how the immune system in humans works to prevent infections and disease. The immune system plays a critical role in preventing infections and tumor development, yet defects in the immune system can lead to disease. This research is focused on understanding inflammatory …

TROPICS

D
Daniel Cater
1 years - 17 years
All genders
Build decision support tools that can be used in future clinical trials to identify when children with septic shock should or should not be transfused with red blood cells. 

Celiac Disease Database

B
Brandon Sparks
All genders
Celiac disease is an autoimmune disease where the body attacks the gut whenever a person eats gluten, a protein that is found in many grains.  This attack causes damage to the gut, making it hard for the body to absorb nutrients.  The only known treatment for celiac disease is a …

ROCK-D

K
Kenneth Lim
18 years - 100 years
All genders
The purpose of the study is to identify the best diagnostic test that could be used to assess cardiovascular risk in patients on dialysis. The study will also develop a new scoring system that can more accurately calculate the risk of developing an adverse cardiovascular event.

MINI-ROCKET

M
Michelle C. Starr, MD
All genders
Determine differences in international practice patterns of neonatal and infant continuous kidney replacement therapy prescriptions and the relationship between dose and major adverse kidney events

Push-It: Prevent Unnecessary Surgeon Holds of Ingestions for Tracheostomy

O
Owen McCabe
18 years - 100 years
All genders
Interventional
To determine if continuation of enteral feeds up to the time of tracheostomy improves nutritional status as evident by total caloric intake, and has no effect on risk of aspiration as evident by reported feed material in mouth, worsening consolidation or opacification on chest x-ray within 48 hours, increased requirement …

Oral Contraceptive Induced Hepatic Adenomas: Building a Biorepository

C
Craig Lammert, MD
All genders
The purpose of this study is to collect biosamples, in the form of whole blood, saliva, and tissue when available, to create a biorepository for people who have a hepatic adenoma or focal nodular hyperplasia (FNH) or both. Our goal is to find out why some women taking birth control …

A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System

T
Thomas Nowak, MD
18 years - 100 years
All genders
Interventional
What is the purpose of this study?The purpose of this research study is to determine if the Enterra® Therapy System can decrease nausea and vomiting symptoms and improve the quality of life for patients with chronic nausea, with or without vomiting, that have normal gastric emptying. THIS STUDY IS ENROLLING BY …

Sample Collection to Assess Physioxia in Brain Tumors

A
Angela M. Richardson, MD, PhD
All genders
What is the purpose of this study?The purpose of this study is to look at the effect of oxygen on tumor tissue and cerebrospinal fluid(CSF). Tissue in your body is exposed to less oxygen than is in the air around you. Traditional studies use cells and tissue kept in room …

A Phase 3, Open-Label, Multicenter, Single-Arm Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Dulaglutide 3.0 Mg and 4.5 Mg in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus

T
Tamara Hannon, MD
10 years - 17 years
All genders
Phase 3
Interventional
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of dulaglutide 3.0 mg and 4.5 mg in pediatric participants 10 to less than 18 years of age with T2DM.THIS STUDY IS ENROLLING BY INVITATION ONLY
261 - 270 of 684